
==== Front
Case Reports Plast Surg Hand Surg
Case Reports Plast Surg Hand Surg
Case Reports in Plastic Surgery & Hand Surgery
2332-0885
Taylor & Francis

10.1080/23320885.2024.2400138
2400138
Version of Record
Case Report
Case Report
Platelet-Rich Plasma as a Novel, Non-invasive Method to Treat Breast Capsular Contractures: a Case Report
O. T. M. Chan et al.
Chan Owen T. M.
Squire Sarah
Schlesinger S. Larry
PRP Center of Hawaii, Honolulu, HI, USA
CONTACT Owen T. M. Chan bcell111@gmail.com PRP Center of Hawaii, 1401 S. Beretania St., Suite 590, Honolulu, HI 96814, USA
10 9 2024
2024
10 9 2024
11 1 240013821 5 2024
30 8 2024
KnowledgeWorks Global Ltd.9 9 2024
published online in a building issue9 9 2024
© 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group
2024
The Author(s)
https://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.

Abstract

We describe the first examples of breast capsular contracture amelioration using a non-surgical, transdermal treatment with platelet-rich plasma. The treated patients did not experience any complications or significant pain. This report illustrates the potential of a non-invasive treatment option for a common complication of breast augmentation.

Keywords

Platelet-rich plasma
capsular contracture
non-invasive
breast augmentation
transdermal electroporation
==== Body
pmcIntroduction

Capsular contractures can be unfortunate sequelae of breast implant surgery caused by a foreign body reaction to the prosthesis and resulting in fibrous encapsulation [1,2]. The tightening of the contracture can be deforming to the breast and potentially painful. The severity of capsular contractures typically is graded by the semi-quantitative Baker system describing the breast: Grade I – Natural, normally soft; Grade II – Minimal, little firm but looks normal; Grade III – Moderate, firm and looks abnormal; Grade IV – Severe, hard, painful, and looks abnormal [3–5].

Multiple approaches for the management of capsular contractures have been described. Conventional methods involve surgery; more specifically, contractures are treated with a capsulotomy or capsulectomy [6,7]. Other surgical interventions include autologous fat transfer [8,9]. Surgery has disadvantages, which include cost, need for recovery time, and infection risk. These shortcomings are compounded if a contracture recurs.

There are also a variety of non-surgical treatments for capsular contractures. These include leukotriene antagonists (such as Zafirlukast) [10,11], botulinum toxin A [12,13], steroids [14], ultrasound [15], and low-level lasers [16]. However, such therapies have variable degrees of efficacy [17].

Herein, we describe the first published report of utilizing platelet-rich plasma (PRP) as an effective, non-surgical modality to treat breast capsular contractures.

Case presentation

Case study – 1

Patient 1 is a 36-year-old woman with a history of a prior, bilateral, dual plane breast augmentation with silicone, smooth implants (left and right-535 mL) and a subsequent, right-sided removal and replacement by a similar implant of the same volume (right-535 mL) due to asymmetry. After 9.6 months, the right breast developed a capsular contracture affecting the right areola with a Baker grade of II–III. PRP generated from the patient was applied topically to the affected area and impelled into the skin and underlying soft tissue via transdermal electroporation. After three treatment sessions with PRP over a 9-week period, the right breast contracture was reduced; and the breast was softer with a Baker grade of I–II (Figure 1).

Figure 1. Patient 1: Pre-treatment internal subcuticular scarring causing a Baker grade II–III capsular contracture secondary to breast implant placement (a). Post-treatment reduction of capsular contracture (B).

Case study – 2

Patient 2 is a 45-year-old woman with a history of prior, bilateral breast augmentation status-post removal. She subsequently had a bilateral, dual plane breast augmentation with silicone, smooth implants (left and right-535 mL). After 6 months, the patient’s right breast developed firmness. Treatment for a potential contracture was initiated using ultrasound therapy and Zafirlukast; however, the firmness continued to progress. After 1.7 years since implantation, the right breast had a capsular contracture with a Baker grade of III; and the breasts were asymmetric with the right breast raised more superiorly than the left breast. Then, the patient elected to undergo PRP therapy. PRP generated from the patient was applied to the affected breast using transdermal electroporation. After six treatments with PRP over a 14-week period, the breast was softer and began to regain symmetry, demonstrating a Baker grade of I–II (Figure 2).

Figure 2. Patient 2: the patient initially developed a capsular contracture of the right breast with a Baker grade of III, where the right breast migrated asymmetrically more superior than the left breast. Treatment of the right breast was initiated with PRP. Photos after one treatment (A) and after five treatments (B). The right breast had a final Baker grade of I–II with improvement of the horizontal alignment of the breasts. It should be noted that photos do not readily demonstrate the progressive softness of the right breast.

Discussion

Capsular contractures are an immune response to foreign material placed inside the human body [18], where such objects include orthopedic hardware, pacemakers, breast implants, etc. The result is the development of collagenous fibrosis around these foreign bodies.

Across many medical specialties, PRP has been used to treat a variety of indications, including fibrosis. In orthopedics, PRP has been injected into joints to treat adhesive capsulitis [19–21], which is an inflammatory condition characterized by fibroblastic proliferation and extensive scar tissue formation in the shoulder that causes stiffness, pain, and loss of passive range of motion. In dermatology, PRP has been utilized to reduce cutaneous scars [22,23]. Such therapies have reported effectiveness with a good safety profile.

Most important to plastic surgeons are capsular contractures in relation to breast implants. When dealing with any attempt to remove a capsular contracture, two important factors in the treatment are (1) to be successful and (2) to minimize any pain. In the current report, the authors describe patients whose breast capsular contractures were successfully reduced with a pain-free and safe treatment utilizing PRP. The current technique is convenient and requires no post-treatment recovery time.

In this report, PRP was generated by first harvesting patient autologous blood. Then specimens were centrifuged once at 3000–3500 revolutions per minute for 10–15 min. Platelet-rich plasma was collected with leukocytes into a separate container. The PRP was applied without activators or any significant fibrin network.

With the current method, the PRP was delivered by a novel system based on transdermal electroporation. Electroporation or electropermeabilization is the transitory, structural perturbation of lipid bilayer membranes due to the application of high voltage, short duration pulses; and this method has been used for the cutaneous delivery of drugs [24,25]. Electroporation is also capable of actively delivering large molecules through the stratum corneum of the skin [26,27], similar to this report. For the current patients, it is hypothesized that the transdermal electroporation introduces the PRP into the skin; and then the PRP subsequently diffuses deeper to disrupt the contracture. This effect is magnified after several applications of PRP over time.

The current manuscript describes the observation that PRP can reduce breast capsular contractures; however, the exact mechanism of action for contracture dissolution has not been elucidated presently. One hypothesis involves the collagenase activity of platelets [28]. Matrix metalloproteinases (MMP) have been identified within platelets, and a subset of these proteinases can degrade fibrillar collagen [29–31]. The platelets of PRP could bind to the collagen of capsular contractures and induce the release of these factors to disrupt the fibrosis. Another potential mechanism could involve the inhibition of myofibroblasts, which are found within capsular contractures, and their contractile activity that contributes to breast distortion [32–36]. The platelets of PRP may release proteins (such as fibroblast growth factor [37] or hepatocyte growth factor [38]) that are known to inhibit myofibroblasts [39,40] and, thereby, reduce breast deformation.

Conclusion

This case report introduces the potential of platelet-rich plasma as a non-surgical, relatively pain-free therapy for breast capsular contractures. In addition to inhibiting the contractures of these patients, the current PRP method yielded no significant complications; and the patients were able to immediately resume their usual activities post-treatment. In comparison to the conventional, surgical methods of treating capsular contractures, this technique with PRP is convenient, is less expensive, and does not carry the same complication risks as invasive procedures. This report also demonstrates that the introduction of PRP via transdermal electroporation and without surgery or injection is possible.

A greater patient sample size is required to confirm efficacy and an absence of significant side effects, and the authors are currently underway to evaluate these. It is plausible that the current technique may not remove a patient’s capsular contracture entirely; however, the aim here is to decrease the severity of the contracture; thereby, providing some relief without surgical treatment risks. This case report first illustrates the potential of PRP as a safe, efficacious modality that could be added to the armamentarium of managing breast capsular contractures.

Acknowledgments

The authors extend our sincere thanks to our patients for allowing us to treat them and for their willingness to share their experiences in this case report, so that others may have this therapeutic option in the future. Warm gratitude is extended also to Honey Millon, Arlene Uchigakiuchi, Calera Schlesinger, Brandi Yoshida, Shanalei Bolusan, and Pamela Palmer for their support with this project.

Author contributions

All of the authors discussed, reviewed, and agreed with the final version of the manuscript.

Informed consent

Informed consent from the patients has been obtained for usage of their clinical details and clinical photographs for publication.

Disclosure statement

A provisional patent application for the described process has been filed.
==== Refs
References

1 Bachour Y. Capsular contracture in breast implant surgery: where are we now and where are we going? Aesthetic Plast Surg. 2021;45 (3 ):1328–1337. doi: 10.1007/s00266-021-02141-6.33559094
2 Headon H, Kasem A, Mokbel K. Capsular contracture after breast augmentation: an update for clinical practice. Arch Plast Surg. 2015;42 (5 ):532–543. doi: 10.5999/aps.2015.42.5.532.26430623
3 Baker JL. Augmentation mammaplasty. Plastic surgery. 3rd ed. Boston: Little, Brown and Company; 1979.
4 Holmes JD. Capsular contracture after breast reconstruction with tissue expansion. Br J Plast Surg. 1989;42 (5 ):591–594. doi: 10.1016/0007-1226(89)90052-0.2804529
5 Health C for D and R. Risks and Complications of Breast Implants. FDA [Internet]. 2023 [cited 2024 May 1]; Available from: https://www.fda.gov/medical-devices/breast-implants/risks-and-complications-breast-implants.
6 Zingaretti N, Vittorini P, Savino V, et al. Surgical treatment of Capsular Contracture (CC): literature review and outcomes utilizing implants in revisionary surgery. Aesthetic Plast Surg. 2021;45 (5 ):2036–2047. doi: 10.1007/s00266-021-02148-z.33543344
7 Hidalgo DA, Weinstein AL. Surgical treatment for capsular contracture: a new paradigm and algorithm. Plast Reconstr Surg. 2020;146 (3 ):516–525. doi: 10.1097/PRS.0000000000007079.32842102
8 Papadopoulos S, Vidovic G, Neid M, et al. using fat grafting to treat breast implant capsular contracture. Plast Reconstr Surg Glob Open. 2018;6 (11 ):e1969. doi: 10.1097/GOX.0000000000001969.30881786
9 Jeong TK, Han JW, Min KH. Treatment of capsular contracture after breast augmentation with serial fat grafting and implantation. Arch Aesthetic Plast Surg. 2018;24 (2 ):68–71. doi: 10.14730/aaps.2018.24.2.68.
10 Schlesinger SL, Ellenbogen R, Desvigne MN, et al. Zafirlukast (Accolate): a new treatment for capsular contracture. Aesthet Surg J. 2002;22 (4 ):329–336. doi: 10.1067/maj.2002.126753.19331987
11 Pașca A, Bonci E-A, Chiuzan C, et al. Treatment and prevention of periprosthetic capsular contracture in breast surgery with prosthesis using leukotriene receptor antagonists: a meta-analysis. Aesthet Surg J. 2022;42 (5 ):483–494. doi: 10.1093/asj/sjab355.34618886
12 Li T, Liu Y, Zhang W. Botulinum toxin A plays an important role in the placement of implants deep within the pectoralis major muscle for mammaplasty: a systematic review and meta-analysis. Aesthetic Plast Surg. 2018;42 (6 ):1519–1530. doi: 10.1007/s00266-018-1203-1.30083802
13 Zikiryakhodzhaev AD, Alekseeva GS, Reshetov IV, et al. Botulinum toxin type A as a tool for correcting capsular contracture after reconstructive breast surgery. Plast Reconstr Surg Glob Open. 2021;9 (1 ):e3372. doi: 10.1097/GOX.0000000000003372.33552818
14 Lemperle G, Exner K. Effect of cortisone on capsular contracture in double-lumen breast implants: ten years’ experience. Aesthetic Plast Surg. 1993;17 (4 ):317–323. doi: 10.1007/BF00437105.8273534
15 Silversmith PE. Ultrasound for capsular contracture of the breast. Plast Reconstr Surg. 1984;73 (3 ):500. doi: 10.1097/00006534-198403000-00035.
16 Azimi F, Flitcroft K, Mathieu E, et al. Low-level laser treatment is ineffective for capsular contracture: results of the LaTCon randomized controlled trial. Plast Reconstr Surg. 2018;142 (5 ):621e–631e. doi: 10.1097/PRS.0000000000004826.29879002
17 Papaconstantinou A, Koletsa T, Demiri E, et al. Nonsurgical treatment of capsular contracture: review of clinical studies. J Int Med Res. 2020;48 (6 ):300060520927873. doi: 10.1177/0300060520927873.32496144
18 Safran T, Nepon H, Chu CK, et al. Current concepts in capsular contracture: pathophysiology, prevention, and management. Semin Plast Surg. 2021;35 (3 ):189–197. doi: 10.1055/s-0041-1731793.34526867
19 Blanchard E, Harvi J, Vasudevan J, et al. Platelet-rich plasma for adhesive capsulitis: a systematic review. Cureus. 2023;15 (10 ):e46580. doi: 10.7759/cureus.46580.37808592
20 Haider SI, Awais MZ, Iqbal MT. Role of platelet-rich plasma in the treatment of adhesive capsulitis: a prospective cohort study. Cureus. 2022;14 (10 ):e30542. doi: 10.7759/cureus.30542.36420240
21 Thu AC, Kwak SG, Shein WN, et al. Comparison of ultrasound-guided platelet-rich plasma injection and conventional physical therapy for management of adhesive capsulitis: a randomized trial. J Int Med Res. 2020;48 (12 ):300060520976032. doi: 10.1177/0300060520976032.33296615
22 Ebrahimi Z, Alimohamadi Y, Janani M, et al. Platelet-rich plasma in the treatment of scars, to suggest or not to suggest? A systematic review and meta-analysis. J Tissue Eng Regen Med. 2022;16 (10 ):875–899. doi: 10.1002/term.3338.35795892
23 Alser OH, Goutos I. The evidence behind the use of platelet-rich plasma (PRP) in scar management: a literature review. Scars Burn Heal. 2018;4 :2059513118808773. doi: 10.1177/2059513118808773.30479843
24 Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26 (11 ):1261–1268. doi: 10.1038/nbt.1504.18997767
25 Zorec B, Préat V, Miklavčič D, et al. Active enhancement methods for intra- and transdermal drug delivery: a review. Zdrav Vestn. 2013;82 :339–356.
26 Pliquett U, Weaver JC. Feasibility of an electrode-reservoir device for transdermal drug delivery by noninvasive skin electroporation. IEEE Trans Biomed Eng. 2007;54 (3 ):536–538. doi: 10.1109/TBME.2006.886828.17355067
27 Denet A-R, Vanbever R, Préat V. Skin electroporation for transdermal and topical delivery. Adv Drug Deliv Rev. 2004;56 (5 ):659–674. doi: 10.1016/j.addr.2003.10.027.15019751
28 Human platelet collagenase - PubMed. [Internet]. [cited 2024 May 13]. Available from: https://pubmed-ncbi-nlm-nih-gov.eres.library.manoa.hawaii.edu/4364408/.
29 Mastenbroek TG, Feijge MAH, Kremers RMW, et al. Platelet-associated matrix metalloproteinases regulate thrombus formation and exert local collagenolytic activity. Arterioscler Thromb Vasc Biol. 2015;35 (12 ):2554–2561. doi: 10.1161/ATVBAHA.115.306153.26471268
30 Gresele P, Falcinelli E, Sebastiano M, et al. Matrix metalloproteinases and platelet function. Prog Mol Biol Transl Sci. 2017;147 :133–165. doi: 10.1016/bs.pmbts.2017.01.002.28413027
31 Santos-Martínez MJ, Medina C, Jurasz P, et al. Role of metalloproteinases in platelet function. Thromb Res. 2008;121 (4 ):535–542. doi: 10.1016/j.thromres.2007.06.002.17681591
32 Rudolph R, Abraham J, Vecchione T, et al. Myofibroblasts and free silicon around breast implants. Plast Reconstr Surg. 1978;62 (2 ):185–196. doi: 10.1097/00006534-197808000-00006.678332
33 Baker JL, Chandler ML, LeVier RR. Occurrence and activity of myofibroblasts in human capsular tissue surrounding mammary implants. Plast Reconstr Surg. 1981;68 (6 ):905–912. doi: 10.1097/00006534-198112000-00010.7301985
34 Coleman DJ, Sharpe DT, Naylor IL, et al. The role of the contractile fibroblast in the capsules around tissue expanders and implants. Br J Plast Surg. 1993;46 (7 ):547–556. doi: 10.1016/0007-1226(93)90104-j.8252260
35 Hwang K, Sim HB, Huan F, et al. Myofibroblasts and capsular tissue tension in breast capsular contracture. Aesthetic Plast Surg. 2010;34 (6 ):716–721. doi: 10.1007/s00266-010-9532-8.20512331
36 Bui JM, Perry T, Ren CD, et al. Histological characterization of human breast implant capsules. Aesthetic Plast Surg. 2015;39 (3 ):306–315. doi: 10.1007/s00266-014-0439-7.25743110
37 Durante C, Agostini F, Abbruzzese L, et al. Growth factor release from platelet concentrates: analytic quantification and characterization for clinical applications. Vox Sang. 2013;105 (2 ):129–136. doi: 10.1111/vox.12039.23639058
38 Nakamura T, Nawa K, Ichihara A, et al. Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett. 1987;224 (2 ):311–316. doi: 10.1016/0014-5793(87)80475-1.3319692
39 Yang X, Chen B, Liu T, et al. Reversal of myofibroblast differentiation: a review. Eur J Pharmacol. 2014;734 :83–90. doi: 10.1016/j.ejphar.2014.04.007.24742377
40 Anitua E, Troya M, Orive G. Plasma rich in growth factors promote gingival tissue regeneration by stimulating fibroblast proliferation and migration and by blocking transforming growth factor-β1-induced myodifferentiation. J Periodontol. 2012;83 (8 ):1028–1037. doi: 10.1902/jop.2011.110505.22145805
